Table 1 Participant baseline characteristics
From: A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
Sex | Placebo (N = 10) N F: 5 M: 5 | Range | Oxytocin (N = 8) N F: 4 M: 4 | Range | Total (N = 18) N F: 9 M: 9 | Range | p-value | |
|---|---|---|---|---|---|---|---|---|
Mean (SD) | Â | Mean (SD) | Â | Mean (SD) | Â | |||
Age (years) | 9.8 (3.6) | 6–17 | 6.8 (1.4) | 5–9 | 8.4 (3.2) | 5–17 | 0.055 | |
Baseline ABC-SW | 20.1 (6.1) | 12–30 | 14 (3.4) | 12–20 | 17.4 (5.9) | 12–30 | 0.012* | |
Verbal DQ | 14.9 (12.8) | 4–46 | 26.4 (21.3) | 8–61 | 20 (17.6) | 4–61 | 0.203 | |
Nonverbal DQ | 20.1 (11.7) | 4–42 | 26.1 (13.1) | 11–50 | 22.7 (12.3) | 4–50 | 0.408 | |
Full Scale DQ | 17.4 (11.8) | 5–44 | 26.3 (16.7) | 10–50 | 21.4 (14.5) | 5–50 | 0.173 | |